Pandora A/S (0NQC)
London Exchange · UK · prices in DKK · close of 19 Oct 2026
Key indicators
| Last close | DKK 850.40 |
|---|---|
| 52-week range | 431.00 – 870.00 |
| Return, 1 month / 3 months | +7.6% / +8.8% |
| Return, 1 year / 3 years | +7.6% / +15.9% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -49.1% |
| Average daily value traded | 35.40M DKK |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pandora is a Danish jewellery company based in Copenhagen that designs and sells charms, charm bracelets, rings, necklaces and earrings. Customers can build and personalise pieces, and the company sells through its own stores and through retail partners in many countries. Its jewellery is made from materials such as silver, gold and glass, and the brand is aimed at a broad consumer market rather than at luxury buyers alone.
On this site Pandora A/S appears as a stock on the London Exchange (UK), code 0NQC, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pandora A/S (0NQC) trades on the London Exchange in UK. It last closed at DKK 850.40 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 660 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.6% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 33.5% | ||
| From 52-week high | -2.3% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | 61.5% | ||
| 12-month return, skipping the last month | 0.1% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.1% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 35.40M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 75 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.9% |
|---|---|
| 1 month | +7.6% |
| 3 months | +8.8% |
| 6 months | +61.5% |
| 1 year | +7.6% |
| 3 years | +15.9% |
| 5 years | +13.0% |
Signals
| 50-day / 200-day average | 817.25 / 637.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 20.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Mar 2026 | DKK 22.0000 |
| 13 Mar 2025 | DKK 20.0000 |
| 15 Mar 2024 | DKK 18.0000 |
| 17 Mar 2023 | DKK 16.0000 |
| 11 Mar 2022 | DKK 16.0000 |
| 15 Nov 2021 | DKK 5.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.